Home|Journals Follow on Twitter| Subscribe to List

Directory for Medical Articles

Open Access

Original Research

Comparative evaluation of ACE inhibitors with or without statins in the treatment of essential hypertension in a tertiary care teaching hospital at Dehradun, Uttarakhand

Shalu Bawa, Shaktibala Dutta, Amit Varma, Hitender Kumar, Mirza Atif Beg, Mohammad Anjoom.

Background: The beneficial effects of statins on the vasculature are present early after statin administration and appear to be independent of their cholesterol-lowering actions. The pleiotropic effects of statins have prompted this study to evaluate their role in hypertension.

Objective: To compare the antihypertensive effects of ACE inhibitors either alone or in combination with statins in a tertiary care teaching hospital at Dehradun, Uttarakhand.

Materials and Methods: The study was conducted in 20 hypertensive patients by the Pharmacology Department in Medicine OPD at Shri Guru Ram Rai Institute of Medical and Health Sciences (SGRRIM & HS), Dehradun, for 1 year from January 2012 to December 2012. Initially, patients were stabilized for 4 weeks by ACE inhibitors and then subdivided into two groups. Group I: ACE inhibitors (n = 10) and Group II: ACE inhibitors + statins (n = 10). Patients were followed up every 4 weeks for 16 weeks. Systolic blood pressure (SBP), diastolic blood pressure (DBP), waist hip ratio (WHR), and body mass index (BMI) were done every visit. Lipid profile was done at 4 and 16 weeks. Primary end points were changes in SBP and DBP. Secondary end points were changes in BMI, WHR, and lipid profile. Analysis was done by paired and unpaired t test. p ≤ 0.05 was significant.

Results: At 4 and 16 weeks, SBP in Group I was 131.6 3.42 and 123.8 2.24 mmHg (p < 0.05) and in Group II was 138.2 3.13 and 126 1.86 mmHg (p < 0.01), respectively. At 4 and 16 weeks, DBP in Group I was 84.4 1.17 and 80.4 0.41 mmHg (p < 0.05) and in Group II was 85.6 1.58 and 81.8 0.91 mmHg (p < 0.05), respectively. At 16 weeks, intergroup SBP and DBP comparison was done, which was not significant (p > 0.05).At 4 and 16 weeks, lipid profile in Group I was insignificant (p > 0.05), in Group II was significant (p < 0.05). Both BMI and WHR in Groups I and II at 4 and 16 weeks were insignificant (p > 0.05).

Conclusion: Both groups showed significant improvement in SBP and DBP. But no significant difference was seen on intergroup comparison at the end of the study period. Longer-duration studies with larger sample size are needed to establish the role of statins in hypertension.

Key words: ACE inhibitors, statins, hypertension, body mass index, waist hip ratio

Share this Article

American Journal of Research in Medical Sciences


BiblioMed Home
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.